Login / Signup

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma.

Anthony WakedMelissa CrabbéVirginie NeirinckxSunay Rodriguez PérezJasmien WellensBernard RogisterM Abderrafi BenotmaneKoen Vermeulen
Published in: EJNMMI radiopharmacy and chemistry (2024)
Lu]Lu-DOTA-POL3026 for CXCR4-TRT in the context of GBM.
Keyphrases
  • cell migration
  • pet ct
  • cell therapy
  • cancer therapy
  • pet imaging
  • computed tomography
  • drug delivery
  • mesenchymal stem cells
  • positron emission tomography